1
Home
Companies

OHR Pharmaceutical

OHR Pharmaceutical
Leadership team

Robert Zamboni (Chief of Preclinical Development & Member of Scientific Advisory Board)

Franklyn G. Prendergast (Independent Director)

Danith H. Ly (Member of Advisory Board)

Products/ Services
Biotechnology, Health Care, Pharmaceutical
Number of Employees
0 - 50
Headquarters
New York, New York, United States
Established
2009
Company Registration
SEC CIK number: 0001173281
Traded as
NASDAQ:OHRP
Social Media
URL
ohrpharmaceutical.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
OHR Pharmaceutical is a biopharmaceutical company focused on the development of therapies to treat ocular diseases in the areas of angiogenesis and inflammation.
History

OHR Pharmaceutical, Inc. is a biopharmaceutical company founded in 2002. The company specializes in developing treatments for diseases of the eye such as wet age-related macular degeneration, diabetic macular edema, and central serous chorioretinopathy.

Mission
To develop innovative therapeutics for diseases of the eye that are safe and effective.
Vision
To be a leader in eye care medicine and make a positive impact on the lives of those suffering from age-related eye diseases.
Key Team

Robert Friedlander (Chair of Scientific Advisory Board)

Eriks Rozners (Member of Scientific Advisory Board)

Gerald J. Mcdougall (Independent Director)

Eric I. Richman (Independent Director)

Dietrich A. Stephan (Founder, CEO & Director)

Steven F. Dowdy (Member of Scientific Advisory Board)

Peter Nielsen (Member of Scientific Advisory Board)

Randy Davis (Member of Scientific Advisory Board)

Dov A. Goldstein (Independent Chairperson)

Robert J. Zamboni (Chief of Preclinical Development & Member of Scientific Advisory Board)

Eric J. Ende (Independent Director)

George McDonald Church (Member of Scientific Advisory Board)

Recognition and Awards
OHR Pharmaceutical has received several awards over the years, including Top 50 Biotechs of 2018, Top Biotech of 2017, and Top 5 Ophthalmology Companies of 2019.
References

https://in.investing.com/equities/ohr-pharmaceuticals-inc

https://www.crunchbase.com/organization/ohr-pharmaceutical

ohrpharmaceutical.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

OHR Pharmaceutical
Leadership team

Robert Zamboni (Chief of Preclinical Development & Member of Scientific Advisory Board)

Franklyn G. Prendergast (Independent Director)

Danith H. Ly (Member of Advisory Board)

Products/ Services
Biotechnology, Health Care, Pharmaceutical
Number of Employees
0 - 50
Headquarters
New York, New York, United States
Established
2009
Company Registration
SEC CIK number: 0001173281
Traded as
NASDAQ:OHRP
Social Media
URL
ohrpharmaceutical.com